139 related articles for article (PubMed ID: 24592140)
1. The efficacy of oral glutamine in prevention of acute radiotherapy-induced esophagitis in patients with lung cancer.
Tutanc OD; Aydogan A; Akkucuk S; Sunbul AT; Zincircioglu SB; Alpagat G; Erden ES
Contemp Oncol (Pozn); 2013; 17(6):520-4. PubMed ID: 24592140
[TBL] [Abstract][Full Text] [Related]
2. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
Topkan E; Yavuz MN; Onal C; Yavuz AA
Lung Cancer; 2009 Mar; 63(3):393-9. PubMed ID: 18691789
[TBL] [Abstract][Full Text] [Related]
3. Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.
Alshawa A; Cadena AP; Stephen B; Reddy A; Mendoza TR; McQuinn L; Lawhorn K; Zarifa A; Bernhardt AM; Fessaheye S; Warneke CL; Chang JY; Naing A
Invest New Drugs; 2021 Aug; 39(4):1113-1122. PubMed ID: 33580845
[TBL] [Abstract][Full Text] [Related]
4. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
Werner-Wasik M; Pequignot E; Leeper D; Hauck W; Curran W
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):689-96. PubMed ID: 11020565
[TBL] [Abstract][Full Text] [Related]
5. Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study.
Algara M; Rodríguez N; Viñals P; Lacruz M; Foro P; Reig A; Quera J; Lozano J; Fernández-Velilla E; Membrive I; Dengra J; Sanz X
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):342-9. PubMed ID: 17531398
[TBL] [Abstract][Full Text] [Related]
6. Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients.
Gul K; Muge A; Taner A; Sehri E
Asian Pac J Cancer Prev; 2015; 16(1):53-8. PubMed ID: 25640390
[TBL] [Abstract][Full Text] [Related]
7. The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy.
Gul K; Mehmet K; Meryem A
Clin Nutr; 2017 Aug; 36(4):1022-1028. PubMed ID: 27373496
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: a retrospective study.
Vidal-Casariego A; Calleja-Fernández A; Ballesteros-Pomar MD; Cano-Rodríguez I
Nutr Cancer; 2013; 65(3):424-9. PubMed ID: 23530642
[TBL] [Abstract][Full Text] [Related]
9. Use of oral glutamine in radiation-induced adverse effects in patients with thoracic and upper aerodigestive malignancies: Results of a prospective observational study.
Papanikolopoulou A; Syrigos N; Vini L; Papasavva M; Lazopoulos G; Kteniadakis S; Spandidos DA; Charpidou A; Drakoulis N
Oncol Lett; 2022 Jan; 23(1):19. PubMed ID: 34858523
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Antonadou D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
[TBL] [Abstract][Full Text] [Related]
11. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
Chang SC; Lai YC; Hung JC; Chang CY
Medicine (Baltimore); 2019 Feb; 98(8):e14463. PubMed ID: 30813149
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy.
Tang W; Li X; Yu H; Yin X; Zou B; Zhang T; Chen J; Sun X; Liu N; Yu J; Xie P
BMC Cancer; 2021 May; 21(1):585. PubMed ID: 34022830
[TBL] [Abstract][Full Text] [Related]
14. Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.
Topkan E; Parlak C; Topuk S; Pehlivan B
BMC Cancer; 2012 Oct; 12():502. PubMed ID: 23113946
[TBL] [Abstract][Full Text] [Related]
15. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.
Wurstbauer K; Merz F; Sedlmayer F
Strahlenther Onkol; 2009 Aug; 185(8):512-6. PubMed ID: 19652934
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
Bradley J; Deasy JO; Bentzen S; El-Naqa I
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
[TBL] [Abstract][Full Text] [Related]
18. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
Patel AB; Edelman MJ; Kwok Y; Krasna MJ; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1106-12. PubMed ID: 15519781
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemo-radiotherapy-induced Oral Mucositis and Dysphagia in Patients with Oropharynx and Larynx Carcinoma.
Pathak S; Soni TP; Sharma LM; Patni N; Gupta AK
Cureus; 2019 Jun; 11(6):e4855. PubMed ID: 31410338
[TBL] [Abstract][Full Text] [Related]
20. Treatment-related esophagitis.
Werner-Wasik M
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S60-6. PubMed ID: 16015537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
